Polypharmacy and health outcomes among older adults discharged from hospital: results from the CRIME study

Geriatr Gerontol Int. 2015 Feb;15(2):141-6. doi: 10.1111/ggi.12241. Epub 2014 Jan 28.

Abstract

Aim: To investigate if older adults using multiple drugs have an increased risk of rehospitalization and mortality after hospital discharge.

Methods: This was a prospective cohort study carried out in acute care hospitals. The primary outcomes of the study were rehospitalization and mortality within 1 year after discharge from acute care hospitals. The study population was categorized in two groups according to the number of drugs prescribed at hospital discharge: no polypharmacy (<8 drugs) and polypharmacy (≥8 drugs).

Results: The mean age of 480 participants was 78.6±6.8 years ,and half of them (n=238; 49.6%) were using multiple drugs (≥8 drugs). Overall, 65 out of 242 participants (26.9%) in the no polypharmacy group and 92/238 (39.1%) in the polypharmacy group were rehospitalized (P=0.004), and 15 out of 242 (6.2%) in the no polypharmacy and 23 out of 238 (9.7%) in the polypharmacy group died during the 1 year follow up (P=0.16). After adjusting for potential confounders, participants in the polypharmacy group had an increased risk of 1-year rehospitalization as compared with those in the no polypharmacy group (RR=1.81, 95% CI=1.18-2.75). No significant association was observed between mortality and polypharmacy.

Conclusions: Older persons using multiple drugs are at increased risk of rehospitalization. Further studies are required to assess the impact of programs aimed at reducing polypharmacy on health outcomes.

Keywords: hospitalization; mortality; older adults; polypharmacy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Activities of Daily Living
  • Aged
  • Aged, 80 and over
  • Comorbidity
  • Diabetes Mellitus / epidemiology
  • Female
  • Heart Failure / epidemiology
  • Humans
  • Male
  • Myocardial Ischemia / epidemiology
  • Outcome Assessment, Health Care
  • Patient Readmission / statistics & numerical data*
  • Polypharmacy*
  • Surveys and Questionnaires